The Market Doesn't Like What It Sees From Moderna, Inc.'s …

Oct 11, 2024 · After such a large drop in price, Moderna's price-to-sales (or "P/S") ratio of 4.3x might make it look like a strong buy right now compared to the wider Biotechs industry in the …

CouponFollow Extension

$35
OFF

Moderna's Road To Stopping The Red - Seeking Alpha

2 weeks from now

Jan 15, 2025 · Doesn't look like there has been much of a follow through from Friday's AH rally on news of the federal funding. The name is in the $35's instead of the $34's. It looks like the …

seekingalpha.com

$17
OFF

Analysts Tell Moderna Investors To Hold After 2024’s Steep Drop

2 weeks from now

Dec 17, 2024 · As 2024 comes to a close, Moderna has a market cap of $17 billion—a staunch drop from its all-time high of $181 billion in 2021 and $63.8 billion in May. ... Like many …

biospace.com

17%
OFF

1 Critical Thing About Moderna That The Market Is Ignoring

2 weeks from now

Oct 14, 2022 · Top coronavirus vaccine maker Moderna (MRNA-9.17%) used to be one of the stock market's stars. The company soared more than 400% in 2020 after bringing its vaccine …

fool.com

92%
OFF

Moderna Stock Surges After Larry Ellison Touts AI, Cancer …

2 weeks from now

Jan 23, 2025 · Moderna stock peaked at 497.49 in August 2021, at the height of the Covid pandemic. Since then, the stock has fallen precipitously, down 92% over the past four years. …

investors.com

4%
OFF

Do Wall Street Analysts Like Moderna Stock? - MSN

2 weeks from now

Moderna has significantly underperformed the broader market over the past year. MRNA stock has tanked 63.4% over the past 52 weeks and 15.9% on a YTD basis, compared to the S&P …

msn.com

$20
OFF

We Think Moderna Still Has A Future - Seeking Alpha

2 weeks from now

Oct 22, 2024 · Moderna, Inc. (NASDAQ:MRNA) has seen steady weakness in its share price as demand for its COVID-19 vaccine has declined.The company has a $20 billion market …

seekingalpha.com

$1.83
OFF

Moderna's Q3 Earnings Beat Overshadowed By Vaccine Demand

2 weeks from now

Nov 8, 2024 · On Thursday, Moderna Inc. MRNA reported third-quarter revenue of $1.83 billion, beating the consensus of $1.25 billion. The company attributed the growth to higher sales in …

benzinga.com

95%
OFF

After Moderna's Shocking News, Is The Stock A Buy Or A Sell?

2 weeks from now

Sep 14, 2024 · Moderna's (MRNA-3.95%) struggles may last a little longer than expected. The biotech company had seen both sales and its stock price plummet as demand for its …

fool.com

$13
OFF

Do Wall Street Analysts Like Moderna Stock? - Nasdaq

2 weeks from now

2 days ago · Valued at $13.1 billion by market cap, Cambridge, Massachusetts-based Moderna, Inc. operates as a clinical-stage pharmaceutical company. It focuses on discovering and …

nasdaq.com

$1
OFF

Is Moderna Stock A Buy? Breaking Down The Latest Guidance

2 weeks from now

Jan 22, 2025 · Moderna cut its 2025 revenue guidance as it estimates 10 product approvals within the next three years and $1 billion in cost-cutting in 2025. Moderna starts 2025 with $9 billion …

marketbeat.com

25%
OFF

Should You Worry About This Threat To Moderna's Vaccine?

2 weeks from now

May 9, 2021 · Moderna's (MRNA 3.25%) success story is all about its coronavirus vaccine. The product generated a whopping $1.7 billion in revenue in the first quarter and brought the …

fool.com

FAQs about The Market Doesn't Like What It Sees From Moderna, Inc.'s … Coupon?

Does Moderna stock erode investors' wealth?

However, since then, the stock has continued to erode investors’ wealth. On Nov. 7, Moderna's stock price dropped nearly 3% after the release of its mixed Q3 results. The company reported a modest 3.6% year-over-year increase in total revenues to $1.9 billion, surpassing Wall Street's expectations. ...

Does Moderna have a 20 billion market capitalization?

The company has a $20 billion market capitalization as it's continued to capitalize on its impressive portfolio of assets. Welast discussed the company and its focus on building up a pipeline of assets in April. As we'll see throughout this article, Moderna has an impressive asset portfolio that should support future returns. ...

Should you buy Moderna stock now?

If you've held Moderna shares for a while, could lock in a profit if you sold, and are looking to move on to other opportunities, you might consider at least trimming your position. But if you're ready to hold on for a few more years, it could turn out to be a wise move. (And buying the stock now, on the dip, could be a smart move too.) ...

How much will Moderna sell in 2024?

The company now expects $3 billion to $3.1 billion in 2024 sales — a cut of $400 million from the topside of its previous guidance — and $1.5 billion to $2.5 billion in 2025 sales. Previously, Moderna projected $2.5 billion to $3.5 billion in sales for that year. William Blair analyst Myles Minter called Moderna stock a "show-me story." ...

Is Moderna a good investment right now?

And that's why Moderna can be a great investment right now, if you don't mind sitting back and waiting for the storm to pass. Adria Cimino has no position in any of the stocks mentioned. The Motley Fool recommends Moderna. The Motley Fool has a disclosure policy. Moderna held its annual R&D day this week. ...

Will Moderna stock hit a floor this year?

Moderna stock surged more than 8% after Oracle's Ellison said mRNA-based cancer vaccines could be developed in under 48 hours with the help of AI. But sales are expected to hit a floor this year, with profitability, on a strict, as-reported basis, not called for until 2029. Moderna stock is showing bearish fundamentals and technicals. ...